In gastric cancer cells, SOX9 promotes EMT by activating the Hippo-YAP pathway and SOX9 silencing rescued the expression of E-cadherin and downregulated mesenchymal markers N-cadherin, vimentin and SNAIl [165]. This evidence concerns the gene CDH2 and gastric cancer.